An Individualized Anti-Cancer Vaccine Study in Patients With HCC

NCT01995227 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study site change to Thailand

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: AlloVax
BIOLOGICAL: CRCL
BIOLOGICAL: AlloStim

Sponsor

Mirror Biologics, Inc.